Association between HbA1c and lipid profiles in patients with newly diagnosed coronary heart disease at very high-risk ASCVD: a cross-sectional study

Background The relationship between HbA1c and lipid profiles remains unclear in patients newly diagnosed with coronary heart disease (CHD) at very high ASCVD risk. This study investigated this association. Methods A total of 731 such patients were recruited and categorized by HbA1c: ≥6.5%, 5.7%–6.4%, and <5.7%. Lipid profiles were compared. Results Compared with HbA1c < 5.7%, the ≥6.5% group had a higher prevalence of hypertension and diabetes and was older ( P < 0.05). In unadjusted analyses, total cholesterol (182.6 ± 52.4 vs. 170.1 ± 38.7 mg/dL) and triglycerides (median 143.4 [106.6–219.9] vs. 115.9 [89.4–161.1] mg/dL) were higher in the ≥6.5% group ( P < 0.05). LDL-C and HDL-C did not differ significantly, but mean LDL-C exceeded 100 mg/dL in all groups, above the guideline-recommended threshold for very-high-risk patients. Non-HDL-C was higher in the ≥6.5% group than in the <5.7% group but not the 5.7%–6.4% group. RC was higher in the ≥6.5% group than in the 5.7%–6.4% group but not the <5.7% group. TG ≥ 150 mg/dL was more prevalent in the ≥6.5% group than in both lower groups; TC ≥ 200 mg/dL differed only versus the <5.7% group, and RC ≥ 19 mg/dL only versus the 5.7%–6.4% group. After adjustment for sex, age, BMI, smoking, hypertension, and T2DM history, neither RC ≥ 19 mg/dL (aOR=1.506, 95% CI:0.888–2.553, P = 0.129) nor TG ≥ 150 mg/dL (aOR=1.212, 95% CI:0.765–1.919, P = 0.414) remained significant. In a secondary model without T2DM adjustment, RC ≥ 19 mg/dL was associated with HbA1c ≥ 6.5% (aOR=1.650, 95% CI:1.085–2.510, P = 0.019), whereas TG ≥ 150 mg/dL was not (aOR=1.376, 95% CI:0.961–1.971, P = 0.082). Conclusion In very high-risk ASCVD patients with newly diagnosed CHD, LDL-C at diagnosis exceeded guideline-recommended targets. After adjustment for T2DM history, neither RC nor TG remained significantly associated with HbA1c ≥ 6.5%. The RC association was attenuated after accounting for T2DM history, suggesting it is not robust to diabetes status. Future longitudinal studies are needed to clarify whether HbA1c provides additional information beyond T2DM status.

Authors

Institutions

Publication Details

Journal
Frontiers in Cardiovascular Medicine
Published
2026-11-18
DOI
https://doi.org/10.3389/fcvm.2026.1989219
Primary Topic
Diabetes, Cardiovascular Risks, and Lipoproteins
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Association between HbA1c and lipid profiles in patients with newly diagnosed coronary heart disease at very high-risk ASCVD: a cross-sectional study

Chuanchuan Li, Li Lin, Yafeng Zhan
Frontiers in Cardiovascular Medicine
Diabetes, Cardiovascular Risks, and Lipoproteins
article

Association between HbA1c and lipid profiles in patients with newly diagnosed coronary heart disease at very high-risk ASCVD: a cross-sectional study

Chuanchuan Li, Li Lin, Yafeng Zhan
article en

Abstract

Background The relationship between HbA1c and lipid profiles remains unclear in patients newly diagnosed with coronary heart disease (CHD) at very high ASCVD risk. This study investigated this association. Methods A total of 731 such patients were recruited and categorized by HbA1c: ≥6.5%, 5.7%–6.4%, and <5.7%. Lipid profiles were compared. Results Compared with HbA1c < 5.7%, the ≥6.5% group had a higher prevalence of hypertension and diabetes and was older ( P < 0.05). In unadjusted analyses, total cholesterol (182.6 ± 52.4 vs. 170.1 ± 38.7 mg/dL) and triglycerides (median 143.4 [106.6–219.9] vs. 115.9 [89.4–161.1] mg/dL) were higher in the ≥6.5% group ( P < 0.05). LDL-C and HDL-C did not differ significantly, but mean LDL-C exceeded 100 mg/dL in all groups, above the guideline-recommended threshold for very-high-risk patients. Non-HDL-C was higher in the ≥6.5% group than in the <5.7% group but not the 5.7%–6.4% group. RC was higher in the ≥6.5% group than in the 5.7%–6.4% group but not the <5.7% group. TG ≥ 150 mg/dL was more prevalent in the ≥6.5% group than in both lower groups; TC ≥ 200 mg/dL differed only versus the <5.7% group, and RC ≥ 19 mg/dL only versus the 5.7%–6.4% group. After adjustment for sex, age, BMI, smoking, hypertension, and T2DM history, neither RC ≥ 19 mg/dL (aOR=1.506, 95% CI:0.888–2.553, P = 0.129) nor TG ≥ 150 mg/dL (aOR=1.212, 95% CI:0.765–1.919, P = 0.414) remained significant. In a secondary model without T2DM adjustment, RC ≥ 19 mg/dL was associated with HbA1c ≥ 6.5% (aOR=1.650, 95% CI:1.085–2.510, P = 0.019), whereas TG ≥ 150 mg/dL was not (aOR=1.376, 95% CI:0.961–1.971, P = 0.082). Conclusion In very high-risk ASCVD patients with newly diagnosed CHD, LDL-C at diagnosis exceeded guideline-recommended targets. After adjustment for T2DM history, neither RC nor TG remained significantly associated with HbA1c ≥ 6.5%. The RC association was attenuated after accounting for T2DM history, suggesting it is not robust to diabetes status. Future longitudinal studies are needed to clarify whether HbA1c provides additional information beyond T2DM status.

Frontiers in Cardiovascular MedicineVol. 13
Fujian Medical University (CN), Union Hospital (CN)
Good health and well-being
Diabetes, Cardiovascular Risks, and Lipoproteins
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon